Tissue concentrations of levonorgestrel in women using a levonorgestrel‐releasing IUD

CG Nilsson, M Haukkamaa, H Vierola… - Clinical …, 1982 - Wiley Online Library
Thirteen women who were scheduled for hysterectomy volunteered for the study. Nine
women had a levonorgestrel‐releasing intrauterine contraceptive device inserted between …

Mirena®(Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception

S Rose, A Chaudhari, CM Peterson - Advanced drug delivery reviews, 2009 - Elsevier
This manuscript serves as a review of Mirena®, the levonorgestrel intrauterine system (LNG
IUS) as a very successful drug delivery system. The LNG IUS has a very high contraceptive …

The production of solid dosage forms from non-degradable polymers

I Major, E Fuenmayor… - Current pharmaceutical …, 2016 - ingentaconnect.com
Non-degradable polymers have an important function in medicine. Solid dosage forms for
longer term implantation require to be constructed from materials that will not degrade or …

Ovarian function during use of vaginal rings delivering three different doses of Nestorone®

V Brache, DR Mishell, P Lahteenmaki, F Alvarez… - Contraception, 2001 - Elsevier
Contraceptive vaginal rings delivering various progestins alone or in combination with
estrogen have been previously studied, showing adequate steroid vaginal absorption and …

Levonorgestrel and estradiol release from an improved contraceptive vaginal ring

TM Jackanicz - Contraception, 1981 - Elsevier
A contraceptive vaginal ring containing levonorgestrel and estradiol was designed in which
the drug is located in a 0.15-mm layer beneath a 0.25-mm overcoat at the ring's surface …

Implantable drug delivery systems

I Major, S Lastakchi, M Dalton, C McConville - Engineering Drug Delivery …, 2020 - Elsevier
Implantable drug delivery systems provide extended release of a drug for the desired
duration, usually over timespans of months and years. A broad range of materials are …

Controlled-release delivery systems for hormones: a review of their properties and current therapeutic use

LR Beck, VZ Pope - Drugs, 1984 - Springer
Biomedical engineering approaches used to develop controlled-release delivery systems for
hormones are here reviewed regarding system design and therapeutic applications. The …

Bioavailability of levonorgestrel from intravaginal rings in women of low income groups

KM Nair, B Sivakumar, K Prema, BSN Rao - Contraception, 1986 - Elsevier
Two types of intravaginal rings (IVR) containing 50–128 mg of levonorgestrel (LNOG) and
28–60 mg of estradiol were inserted in 18 apparently normal subjects belonging to the low …

Analytical studies of some agents for fertility regulation (Volume 1)

A Belenguer - 1990 - openaccess.city.ac.uk
This Thesis describes three pieces of work, all of which were commissioned by the World
Health Organization Special Programme in Human Reproduction which are concerned with …

[引用][C] Birth control technologies: prospects by the year 2000.

MJK Harper - 1983 - cabidigitallibrary.org
Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …